Zhejiang Gongdong Medical Technology (605369.SH) has obtained the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment (CNAS).
Gongdong Medical (605369.SH) issued an announcement that the company recently received a laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment (CNAS).
Zhejiang Gongdong Medical Technology (605369.SH) announced that the company has recently received the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment (CNAS).
The receipt of the "CNAS Laboratory Accreditation Certificate" signifies that the company's management level and technical capabilities of the testing center have obtained national and international authoritative recognition. The company now has the ability to conduct testing in accordance with national standards, and the test results have international recognition, which helps to reduce the market access thresholds and external testing costs for products both domestically and internationally. This accreditation also provides a solid guarantee for product quality control, performance verification, and research and development innovation, enhancing customer recognition and trust in the company. Furthermore, it demonstrates the company's advantages in technology and quality standard management, contributing to the enhancement of the company's overall competitiveness.
Related Articles

MINTH GROUP (00425) unit of trading is changed to 100 shares per lot.

TRULY INT'L (00732) spent 1.03 million Hong Kong dollars to repurchase 1 million shares on February 2nd.

EVERCHINA INT'L (00202): Zhou Zhizhu resigns as Executive Director and Co-Chief Executive Officer.
MINTH GROUP (00425) unit of trading is changed to 100 shares per lot.

TRULY INT'L (00732) spent 1.03 million Hong Kong dollars to repurchase 1 million shares on February 2nd.

EVERCHINA INT'L (00202): Zhou Zhizhu resigns as Executive Director and Co-Chief Executive Officer.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


